B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue, Arthritis Res Ther, vol.9, p.218, 2007. ,
Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes, J Autoimmun, vol.39, pp.43-51, 2012. ,
Inducible tertiary lymphoid structures, autoimmunity and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice, J Immunol, vol.189, pp.3767-76, 2012. ,
Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome, Arthritis Rheum, vol.48, pp.3187-201, 2003. ,
Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects, Int Arch Allergy Immunol, vol.123, pp.46-57, 2000. ,
Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome. Med Oral Patol Oral Cir Bucal, vol.20, 2015. ,
The epidemiology of Sjögren's syndrome, Clin Epidemiol, vol.6, pp.247-255, 2014. ,
Autoimmunity and infection in Sjögren's syndrome, Curr Opin Rheumatol, vol.25, pp.480-487, 2013. ,
Epstein-Barr virus in systemic autoimmune diseases, J Immunol Res, p.535738, 2013. ,
, , 2001.
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell, Immunity, vol.13, pp.497-506, 2000. ,
Persistence of the epstein-barr virus and the origins of associated lymphomas, N Engl J Med, vol.350, pp.1328-1365, 2004. ,
Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells, Blood, vol.113, pp.604-611, 2009. ,
Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome, Arthritis Rheumatol, vol.66, pp.2545-2557, 2014. ,
Detection of epstein-barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome, Am J Med, vol.90, pp.286-94, 1991. ,
Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome, J Exp Med, vol.169, pp.2191-2199, 1989. ,
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis-association and causation, Viruses, vol.4, pp.3701-3731, 2012. ,
Epstein-Barr virus and rheumatoid arthritis: is there a link?, Arthritis Res Ther, vol.8, p.204, 2006. ,
, Curr Opin Rheumatol, vol.24, pp.383-391, 2012.
Use of Biologics in Sjögren's Syndrome, Rheum Dis Clin North Am, vol.42, pp.407-424, 2016. ,
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era, Oncotarget, vol.7, pp.76934-76943, 2016. ,
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort, PLoS ONE, vol.8, p.59868, 2013. ,
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide, RMD Open, vol.1, p.22, 2015. ,
Pathogenesis of Sjögren's syndrome and therapeutic consequences, Curr Opin Rheumatol, vol.22, pp.471-477, 2010. ,
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains, Clin Chem, vol.48, pp.1437-1444, 2002. ,
Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides, PLoS ONE, vol.7, p.37626, 2012. ,
Elevated concentrations of serum immunoglobulin free light chains in systemic Lupus Erythematosus patients in relation to disease activity, inflammatory status, B Cell Activity and Epstein-Barr virus antibodies, PLoS ONE, vol.10, p.138753, 2015. ,
Efficient isolation of highly purified tonsil B lymphocytes using RosetteSep with allogeneic human red blood cells, BMC Immunol, vol.10, p.30, 2009. ,
Comparison of EBV DNA viral load in whole blood, plasma, B-cells and Bcell culture supernatant, J Med Virol, vol.86, pp.851-856, 2014. ,
The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification, PLoS ONE, vol.12, p.183856, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01890162
Membrane protected apoptotic trophoblast microparticles contain nucleic acids, Am J Pathol, vol.173, pp.1595-1608, 2008. ,
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science, vol.239, pp.487-491, 1988. ,
The 2016 classification criteria for primary Sjogren's syndrome: what's new?, BMC Med, vol.15, p.69, 2017. ,
Sjögren's syndrome (SS) and Epstein-Barr virus (EBV) reactivation, Ocul Immunol Inflamm, vol.2, pp.101-109, 1994. ,
Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome, J Autoimmun, vol.2, pp.427-432, 1989. ,
Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis, J Infect Dis, vol.164, pp.22-28, 1991. ,
EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?, Rheumatol Int, vol.33, pp.1149-1157, 2013. ,
Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review, J Autoimmun, vol.51, pp.17-22, 2014. ,
Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years, J Clin Microbiol, vol.42, pp.3381-3388, 2004. ,
Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma, J Med Virol, vol.79, pp.1710-1721, 2007. ,
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions, World J Virol, vol.1, pp.31-43, 2012. ,
The future of B cell-targeted therapies in Sjögren's syndrome, Immunotherapy, vol.5, pp.639-646, 2013. ,
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study, Rheumatology, vol.54, pp.2249-56, 2015. ,
Efficacy and safety of biological DMARDs modulating B cells in primary Sjögren's syndrome: systematic review and meta-analysis, Joint Bone Spine, vol.85, pp.15-22, 2017. ,
B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.52, pp.33-37, 2011. ,
Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis, Arthritis Rheum, vol.36, pp.827-835, 1993. ,
Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection, J Med Virol, vol.68, pp.378-383, 2002. ,
Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primers, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.28, pp.165-168, 2003. ,
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain, J Exp Med, vol.204, pp.2899-912, 2007. ,
Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis, Eur J Neurol Off J Eur Fed Neurol Soc, vol.17, pp.1263-1272, 2010. ,
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis, Mult Scler, vol.15, pp.153-158, 2009. ,
The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output, PLoS Pathog, vol.5, p.100049, 2009. ,